β‐L actam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: A structured review

MG Sinnollareddy, MS Roberts… - Clinical and …, 2012 - Wiley Online Library
Infections and related sepsis are two of the most prevalent issues in the care of critically ill
patients, with mortality as high as 70%. Appropriate antibiotic selection, as well as adequate …

[HTML][HTML] Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy …

AT Kothekar, JV Divatia, SN Myatra, A Patil… - Annals of intensive …, 2020 - Springer
Background Optimal anti-bacterial activity of meropenem requires maintenance of its plasma
concentration (Cp) above the minimum inhibitory concentration (MIC) of the pathogen for at …

Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes

R Sharma, S Patel, C Abboud, J Diep, NS Ly… - International journal of …, 2017 - Elsevier
Combination therapy provides a useful therapeutic approach to overcome resistance until
new antibiotics become available. In this study, the pharmacodynamics, including the …

Intravenous push administration of antibiotics: literature and considerations

S Spencer, H Ipema, P Hartke, C Krueger… - Hospital …, 2018 - journals.sagepub.com
Intravenous (IV) push administration can provide clinical and practical advantages over
longer IV infusions in multiple clinical scenarios, including in the emergency department, in …

Extended and continuous infusion of novel protected β-lactam antibiotics: a narrative review

F Venuti, M Trunfio, AG Martson, F Lipani… - Drugs, 2023 - Springer
Consolidated data from pharmacokinetic and pharmacodynamic studies support the
administration of β-lactam antibiotics in prolonged infusion (ie, extended or continuous) to …

[HTML][HTML] Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B

TP Lim, W Lee, TY Tan, S Sasikala, J Teo, LY Hsu… - PloS one, 2011 - journals.plos.org
Objective Extreme drug-resistant Pseudomonas aeruginosa (XDR-PA) with decreased
susceptibility to polymyxin B (PB) has emerged in Singapore, causing infections in …

[HTML][HTML] Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae

A Oliva, F Gizzi, MT Mascellino, A Cipolla… - Clinical Microbiology …, 2016 - Elsevier
Available therapeutic options against carbapenem-resistant Klebsiella pneumoniae (CR-Kp)
are limited because of the high level of resistance to other antimicrobial classes including …

Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa

ML Monogue, DP Nicolau - Journal of Antimicrobial …, 2018 - academic.oup.com
Objectives Broad-spectrum antimicrobial resistance in Pseudomonas aeruginosa (PSA)
isolates is a growing concern as our therapeutic options have become significantly limited …

[HTML][HTML] Prolonged versus intermittent infusion of β-lactams for the treatment of nosocomial pneumonia: a meta-analysis

A Lal, P Jaoude, AA El-Solh - Infection & chemotherapy, 2016 - synapse.koreamed.org
Background The primary objective of this meta-analysis is aimed at determining whether β-
lactams prolonged infusion in patients with nosocomial pneumonia (NP) results in higher …

Antimicrobial resistance among and therapeutic options against gram-negative pathogens

JJ Rahal - Clinical infectious diseases, 2009 - academic.oup.com
Gram-negative bacterial pathogens are a common cause of infection, and the prevalence
and rates of resistance among these pathogens to existing antimicrobial agents are …